Fisher & Paykel Healthcare Releases Annual Report and Director Advises Intention to Retire

Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) has provided a copy of the following documents:

  • Annual Report for the year ended 31 March 2015;
  • Annual Review for the year ended 31 March 2015;
  • ASX Appendix 4G – Corporate Governance Statement; and
  • Section 209 notice.


The 2015 Annual Report and Annual Review will be available online at www.fphcare.com/2015annualreport and the Corporate Governance statement will be available at www.fphcare.com/corporategovernance.

The company also announced today that independent director, Roger France, has advised the Board of his intention to retire from the role in the coming year.

Mr France, who has been a director of the company since February 2009, has agreed to remain on the Board until a replacement director is appointed, and will stand for re-election at the upcoming 2015 annual shareholders’ meeting.

Chairman of Fisher & Paykel Healthcare, Tony Carter, commented: “Roger has been a very valuable member of the Board, in addition to his role as chair of the Audit and Risk Committee. Roger’s financial expertise and commercial acumen has been a significant contributing factor in the company’s outstanding growth and performance during his time on the Board.

“We have initiated a search process for a replacement director with appropriate skills and experience, and appreciate Roger’s commitment to the company until an appointment is made.”

Roger France holds a number of other directorships, including Air New Zealand Limited and Orion Health Group Limited, and is a trustee of the University of Auckland Foundation and the Dilworth Trust Board.

About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide.

Contact: Marcus Driller, Investor Relations & Corporate Affairs Manager on +64 9 574 0110